Skip to content

RLYB

Rallybio Corporation

NASDAQ · USHealthcareBiotechnology
$16.71+1.77%

Price as of Jul 20, 2026

RLYB capital

Rallybio Corporation capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.00x
Net debt / equity
-0.82x
Debt / assets
0.00x
Debt / EBITDA
-0.01x
Net debt / EBITDA
1.47x

Liquidity & coverage

Current ratio
12.92x
Quick ratio
12.92x
Cash ratio
11.30x
Interest coverage
EBITDA / interest
Working capital
$49.4M

Cash & dividend

FCF / debt
-179.13x
Cash flow / debt
-179.13x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.